Growth Metrics

Caribou Biosciences (CRBU) Other Gross PP&E Adjustments (2020 - 2026)

Caribou Biosciences (CRBU) reported Other Gross PP&E Adjustments of $2.9 million for Q1 2026, down 77.44% year-over-year from $13.0 million in Q1 2025, and up 173.2% on a QoQ basis from -$4.0 million in Q4 2025.

Caribou Biosciences (CRBU) has 7 years of Other Gross PP&E Adjustments data on file, last reported at $2.9 million in Q1 2026.

  • Quarterly Other Gross PP&E Adjustments fell 77.44% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 77.44% YoY) and the FY2025 annual result came in at -$4.0 million, down 165.07% from the prior year.
  • Other Gross PP&E Adjustments advanced to $2.9 million in Q1 2026 per CRBU's latest filing, from -$4.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $13.0 million in Q1 2025 and bottomed at -$15.3 million in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $2.3 million (2023), against an average of $130411.8.
  • The widest annual swing landed in 2022, when Other Gross PP&E Adjustments tumbled 296.31%; it then jumped 1088.96% in 2024.
  • Tracing CRBU's Other Gross PP&E Adjustments over 5 years: stood at -$10.8 million in 2022, then surged by 105.61% to $607000.0 in 2023, then jumped by 918.29% to $6.2 million in 2024, then tumbled by 165.07% to -$4.0 million in 2025, then jumped by 173.2% to $2.9 million in 2026.
  • Per Business Quant, the three latest CRBU Other Gross PP&E Adjustments figures stand at $2.9 million (Q1 2026), -$4.0 million (Q4 2025), and $4.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Caribou Biosciences 232.46 Mn 114.84 Mn - 2.94 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.94 Mn
Mar 31, 2026 2.94 Mn
Dec 31, 2025 -4.02 Mn
Dec 31, 2025 -4.02 Mn
Sep 30, 2025 4.49 Mn
Sep 30, 2025 4.49 Mn
Jun 30, 2025 3.98 Mn
Jun 30, 2025 3.98 Mn
Mar 31, 2025 13.05 Mn
Mar 31, 2025 13.05 Mn
Dec 31, 2024 6.18 Mn
Dec 31, 2024 6.18 Mn
Sep 30, 2024 10.88 Mn
Sep 30, 2024 10.88 Mn
Jun 30, 2024 9.41 Mn
Jun 30, 2024 9.41 Mn
Mar 31, 2024 7.36 Mn
Mar 31, 2024 7.36 Mn
Dec 31, 2023 607,000.00
Dec 31, 2023 607,000.00
Sep 30, 2023 2.32 Mn
Sep 30, 2023 2.32 Mn
Jun 30, 2023 -951,000.00
Jun 30, 2023 -951,000.00
Mar 31, 2023 -4.86 Mn
Mar 31, 2023 -4.86 Mn
Dec 31, 2022 -10.82 Mn
Dec 31, 2022 -10.82 Mn
Sep 30, 2022 -10.49 Mn
Sep 30, 2022 -10.49 Mn
Jun 30, 2022 -12.51 Mn
Jun 30, 2022 -12.51 Mn
Mar 31, 2022 -15.35 Mn
Mar 31, 2022 -15.35 Mn
Dec 31, 2021 8.39 Mn
Dec 31, 2021 8.39 Mn
Sep 30, 2021 7.88 Mn
Sep 30, 2021 7.88 Mn
Jun 30, 2021 6.37 Mn
Jun 30, 2021 6.37 Mn
Dec 31, 2020 6.40 Mn
Dec 31, 2020 6.40 Mn